Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Low-Dose Taxotere with Radiotherapy for Cervical Cancer
NCT00178269Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Jan 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in Cervical Cancer (CC), sponsored by University of Rochester. Started Jan 2005; status: completed.
02
Drugs
docetaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00178269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178269.